MONITORING THE AUTOPHAGY PATHWAY IN CANCER

被引:6
作者
Dorsey, Frank C. [1 ]
Steeves, Meredith A. [1 ]
Prater, Stephanie M. [1 ]
Schroeter, Thomas [2 ]
Cleveland, John L. [1 ]
机构
[1] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA
[2] Scripps Res Inst, Translat Res Inst, Jupiter, FL USA
来源
METHODS IN ENZYMOLOGY VOL 453: AUTOPHAGY IN DISEASE AND CLINICAL APPLICATIONS, PT C | 2009年 / 453卷
关键词
MYC-INDUCED LYMPHOMAGENESIS; NF-KAPPA-B; TUMOR-SUPPRESSOR; TRANSGENIC MICE; CELL-DEATH; IN-VIVO; TUMORIGENESIS; INFLAMMATION; INHIBITION; BECLIN-1;
D O I
10.1016/S0076-6879(08)04012-3
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Autophagy is an ancient cell survival pathway that is induced by metabolic stress and that helps prevent bioenergetic failure. This pathway has emerged as a promising new target in cancer treatment, where agents that inhibit autophagic degradation have efficacy in preventing cancer and in treating resistant disease when combined with conventional chemotherapeutics, which generally activate the pathway. However, agents that specifically target the autophagy pathway are currently lacking, and monitoring the effects of therapeutics on the autophagy pathway raises several challenges. Here we review the potential roles of the autophagy pathway in tumor progression and in maintenance of the malignant state, and introduce novel methods that we have developed that allow one to monitor autophagic activity ex vivo and in vivo.
引用
收藏
页码:251 / +
页数:24
相关论文
共 35 条
[1]
p53-dependent and p53-independent activation of autophagy by ARF [J].
Abida, Wassirn M. ;
Gu, Wei .
CANCER RESEARCH, 2008, 68 (02) :352-357
[2]
THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[3]
IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation [J].
Alpdogan, Ö ;
Muriglan, SJ ;
Eng, JM ;
Willis, LM ;
Greenberg, AS ;
Kappel, B ;
van den Brink, MRM .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07) :1095-1107
[4]
Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis [J].
Alt, JR ;
Greiner, TC ;
Cleveland, JL ;
Eischen, CM .
EMBO JOURNAL, 2003, 22 (06) :1442-1450
[5]
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma [J].
Amaravadi, Ravi K. ;
Yu, Duonan ;
Lum, Julian J. ;
Bui, Thi ;
Christophorou, Maria A. ;
Evan, Gerard I. ;
Thomas-Tikhonenko, Andrei ;
Thompson, Craig B. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (02) :326-336
[6]
Briceno Eduardo, 2003, Neurosurg Focus, V14, pe3
[7]
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance [J].
Carew, Jennifer S. ;
Nawrocki, Steffan T. ;
Kahue, Charissa N. ;
Zhang, Hui ;
Yang, Chunying ;
Chung, Linda ;
Houghton, Janet A. ;
Huang, Peng ;
Giles, Francis J. ;
Cleveland, John L. .
BLOOD, 2007, 110 (01) :313-322
[8]
Non-autophagic GFP-LC3 puncta induced by saponin and other detergents [J].
Cieehomska, Iwona A. ;
Tolkovsky, Aviva M. .
AUTOPHAGY, 2007, 3 (06) :586-590
[9]
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis [J].
Degenhardt, Kurt ;
Mathew, Robin ;
Beaudoin, Brian ;
Bray, Kevin ;
Anderson, Diana ;
Chen, Guanghua ;
Mukherjee, Chandreyee ;
Shi, Yufang ;
Gelinas, Celine ;
Fan, Yongjun ;
Nelson, Deirdre A. ;
Jin, Shengkan ;
White, Eileen .
CANCER CELL, 2006, 10 (01) :51-64
[10]
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis [J].
Eischen, CM ;
Weber, JD ;
Roussel, MF ;
Sherr, CJ ;
Cleveland, JL .
GENES & DEVELOPMENT, 1999, 13 (20) :2658-2669